Abstract
Chronic myelogenous leukemia (CML) is a malignant disease resulting from the neoplastic transformation of a hematopoietic stem cell. Generation of the BCR–ABL fusion gene plays an essential role in causing the vast majority of CML. Clinical and laboratory studies have indicated that development of CML involves both the effects of BCR–ABL within its correct target cells and interactions of BCR–ABL target cells with the rest of the in vivo environment, and that the progression of the disease to blast crisis involves multiple genetic alterations. An efficient mouse bone marrow transduction and transplantation model for CML has recently been developed. This review summarizes the analysis of the roles of functional domains and downstream signaling pathways of BCR–ABL, of altered cytokine production, of interferon signaling pathways and of oncogene cooperation in the pathogenesis of CML using this murine model. The in vivo studies of leukemogenesis will help to advance mechanism-based therapies for CML, as well as to understand fundamental rules of leukemogenesis and hematopoiesis.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Afar DEH, Goga A, McLaughlin J, Witte ON, Sawyers CL . 1994 Science 264: 424–426
Ahuja HG, Foti A, Bar-Eli M, Cline MJ . 1990 Blood 75: 1684–1690
Ahuja HG, Popplewell L, Tcheurekdjian L, Slovak ML . 2001 Genes Chromosomes Cancer 30: 410–415
Bhatia R, Verfaillie CM . 1998 Leuk. Lymphoma 28: 241–254
Bonifazi F, de Vivo A, Rosti G, Guilhot F, Guilhot J, Trabacchi E, Hehlmann R, Hochhaus A, Shepherd PC, Steegmann JL, Kluin-Nelemans HC, Thaler J, Simonsson B, Louwagie A, Reiffers J, Mahon FX, Montefusco E, Alimena G, Hasford J, Richards S, Saglio G, Testoni N, Martinelli G, Tura S, Baccarani M . 2001 Blood 98: 3074–3081
Bromberg J, Darnell Jr JE . 2000 Oncogene 19: 2468–2473
Buchdunger E, Zimmermann J, Mett H, Meyer T, Muller M, Druker BJ, Lydon NB . 1996 Cancer Res. 56: 100–104
Carlesso N, Frank DA, Griffin JD . 1996 J. Exp. Med. 183: 811–820
Castellanos A, Pintado B, Weruaga E, Arevalo R, Lopez A, Orfao A, Sanchez-Garcia I . 1997 Blood 90: 2168–2174
Castilla LH, Wijmenga C, Wang Q, Stacy T, Speck NA, Eckhaus M, Marin-Padilla M, Collins FS, Wynshaw-Boris A, Liu PP . 1996 Cell 87: 687–696
Colovic M, Jankovic G, Bila J, Djordjevic V, Wiernik PH . 1998 Med. Oncol. 15: 199–201
Cortez D, Kadlec L, Pendergast AM . 1995 Mol. Cell. Biol. 15: 5531–5541
Cuenco GM, Nucifora G, Ren R . 2000 Proc. Natl. Acad. Sci. USA 97: 1760–1765
Cuenco GM, Ren R . 2001 Oncogene 20: 8236–8248
Daley GQ, Van Etten RA, Baltimore D . 1990 Science 247: 824–830
Daley GQ, Van Etten RA, Baltimore D . 1991 Proc. Natl. Acad. Sci. USA 88: 11335–11338
de Groot RP, Raaijmakers JA, Lammers JW, Jove R, Koenderman L . 1999 Blood 94: 1108–1112
Deininger MW, Goldman JM, Melo JV . 2000 Blood 96: 3343–3356
Deng M, Daley GQ . 2001 Blood 97: 3491–3497
Druker BJ, Sawyers CL, Capdeville R, Ford JM, Baccarani M, Goldman JM . 2001 Hematology (Am. Soc. Hematol. Educ. Program) 87–112
Druker BJ, Tamura S, Buchdunger E, Ohno S, Segal GM, Fanning S, Zimmermann J, Lydon NB . 1996 Nat. Med. 2: 561–566
el-Ahmady O, Mansour M, Kamel H, Baker A . 1997 Anticancer Res. 17: 3179–3182
Elefanty AG, Cory S . 1992 Mol. Cell. Biol. 12: 1755–1763
Elefanty AG, Hariharan IK, Cory S . 1990 EMBO J. 9: 1069–1078
Era T, Witte ON . 2000 Proc. Natl. Acad. Sci. USA 97: 1737–1742
Faderl S, Talpaz M, Estrov Z, O'Brien S, Kurzrock R, Kantarjian HM . 1999 N. Engl. J. Med. 341: 164–172
Frank DA, Varticovski L . 1996 Leukemia 10: 1724–1730
Franz WM, Berger P, Wang JYJ . 1989 EMBO J. 8: 137–147
Gabriele L, Phung J, Fukumoto J, Segal D, Wang IM, Giannakakou P, Giese NA, Ozato K, Morse III HC . 1999 J. Exp. Med. 190: 411–421
Ghaffari S, Daley GQ, Lodish HF . 1999 Leukemia 13: 1200–1206
Gishizky ML, Johnson-White J, Witte ON . 1993 Proc. Natl. Acad. Sci. USA 90: 3755–3759
Goga A, McLaughlin J, Afar DE, Saffran DC, Witte ON . 1995 Cell 82: 981–988
Goldman JM, Druker BJ . 2001 Blood 98: 2039–2042
Golub TR, Goga A, Barker GF, Afar DE, McLaughlin J, Bohlander SK, Rowley JD, Witte ON, Gilliland DG . 1996 Mol. Cell. Biol. 16: 4107–4116
Gorre ME, Mohammed M, Ellwood K, Hsu N, Paquette R, Rao PN, Sawyers CL . 2001 Science 293: 876–880
Griffin JD . 2001 Blood 97: A2193
Gross AW, Ren R . 2000 Oncogene 19: 6286–6296
Gross AW, Zhang X, Ren R . 1999 Mol. Cell. Biol. 19: 6918–6928
Hao SX, Ren R . 2000 Mol. Cell. Biol. 20: 1149–1161
Harada H, Taniguchi T, Tanaka N . 1998 Biochimie 80: 641–650
Hawley RG . 1994 Ann. NY Acad. Sci. 716: 327–330
He Y, Wertheim JA, Xu L, Miller JP, Karnell FG, Choi JK, Ren R, Pear WS . 2002 Blood 99: 2957–2968
Heinrich MC, Griffith DJ, Druker BJ, Wait CL, Ott KA, Zigler AJ . 2000 Blood 96: 925–932
Heisterkamp N, Jenster G, Kioussis D, Pattengale PK, Groffen J . 1991 Transgenic Research 1: 45–53
Heisterkamp N, Jenster G, ten Hoeve J, Zovich D, Pattengale PK, Groffen J . 1990 Nature 344: 251–253
Holtschke T, Löhler J, Kanno Y, Fehr T, Giese N, Rosenbauer F, Lou J, Knobeloch K-P, Gabriele L, Waring JF, Bachmann MF, Zinkernagel RM, Morse 3rd HC, Ozato K, Horak I . 1996 Cell 87: 307–317
Honda H, Fujii T, Takatoku M, Mano H, Witte ON, Yazaki Y, Hirai H . 1995 Blood 85: 2853–2861
Honda H, Oda H, Suzuki T, Takahashi T, Witte ON, Ozawa K, Ishikawa T, Yazaki Y, Hirai H . 1998 Blood 91: 2067–2075
Honda H, Ushijima T, Wakazono K, Oda H, Tanaka Y, Aizawa S, Ishikawa T, Yazaki Y, Hirai H . 2000 Blood 95: 1144–1150
Huettner CS, Zhang P, Van Etten RA, Tenen DG . 2000 Nature Genetics 24: 57–60
Ilaria Jr RL, Van Etten RA . 1995 Blood 86: 3897–3904
Ilaria Jr RL, Van Etten RA . 1996 J. Biol. Chem. 271: 31704–31710
Jackson P, Baltimore D . 1989 EMBO J. 8: 449–456
Janssen JW, Ridge SA, Papadopoulos P, Cotter F, Ludwig WD, Fonatsch C, Rieder H, Ostertag W, Bartram CR, Wiedemann LM . 1995 Br. J. Haematol. 90: 222–224
Jiang X, Lopez A, Holyoake T, Eaves A, Eaves C . 1999 Proc. Natl. Acad. Sci. USA 96: 12804–12809
Jonuleit T, Peschel C, Schwab R, van der Kuip H, Buchdunger E, Fischer T, Huber C, Aulitzky WE . 1998 Br. J. Haematol. 100: 295–303
Kantarjian H, Sawyers C, Hochhaus A, Guilhot F, Schiffer C, Gambacorti-Passerini C, Niederwieser D, Resta D, Capdeville R, Zoellner U, Talpaz M, Druker B . 2002 N. Engl. J. Med. 346: 645–652
Kelliher MA, McLaughlin J, Witte ON, Rosenberg N . 1990 Proc. Natl. Acad. Sci. USA 87: 6649–6653
Kelliher MA, Weckstein DJ, Knott AG, Wortis HH, Rosenberg N . 1993 Oncogene 8: 1249–1256
Kieslinger M, Woldman I, Moriggl R, Hofmann J, Marine JC, Ihle JN, Beug H, Decker T . 2000 Genes Dev. 14: 232–244
Landolfo S, Guarini A, Riera L, Gariglio M, Gribaudo C, Cignetti A, Cordone I, Montefusco E, Mandelli F, Foa R . 2000 Hematol. J. 1: 7–14
Li S, Gillessen S, Tomasson MH, Dranoff G, Gilliland DG, Van Etten RA . 2001 Blood 97: 1442–1450
Li S, Ilaria RL, Million RP, Daley GQ, Van Etten RA . 1999 J. Exp. Med. 189: 1399–1412
Matsuyama T, Kimura T, Kitagawa M, Pfeffer K, Kawakami T, Watanabe N, Kundig TM, Amakawa R, Kishihara K, Wakeham A . 1993 Cell 75: 83–97
McLaughlin J, Chianese E, Witte ON . 1987 Proc. Natl. Acad. Sci. USA 84: 6558–6562
McWhirter JR, Gaalasso DL, Wang JYJ . 1993 Mol. Cell. Biol. 13: 7587–7595
Melo JV . 1997 Baillieres Clin. Haematol. 10: 203–222
Meraz MA, White JM, Sheehan KC, Bach EA, Rodig SJ, Dighe AS, Kaplan DH, Riley JK, Greenlund AC, Campbell D, Carver-Moore K, DuBois RN, Clark R, Aguet M, Schreiber RD . 1996 Cell 84: 431–442
Million RP, Van Etten RA . 2000 Blood 96: 664–670
Mittrucker HW, Matsuyama T, Grossman A, Kundig TM, Potter J, Shahinian A, Wakeham A, Patterson B, Ohashi PS, Mak TW . 1997 Science 275: 540–543
Neubauer A, Dodge RK, George SL, Davey FR, Silver RT, Schiffer CA, Mayer RJ, Ball ED, Wurster-Hill D, Bloomfield CD, Liu ET . 1994 Blood 83: 1603–1611
Nguyen H, Hiscott J, Pitha PM . 1998 Cytokine Growth Factor Rev. 8: 293–312
Nieborowska-Skorska M, Wasik MA, Slupianek A, Salomoni P, Kitamura T, Calabretta B, Skorski T . 1999 J. Exp. Med. 189: 1229–1242
Niki M, Okada H, Takano H, Kuno J, Tani K, Hibino H, Asano S, Ito Y, Satake M, Noda T . 1997 Proc. Natl. Acad. Sci. USA 94: 5697–5702
O'Dwyer ME, Druker BJ . 2001 J. Intern. Med. 250: 3–9
Oda T, Tamura S, Matsuguchi T, Griffin JD, Druker BJ . 1995 Leukemia 9: 295–301
Okuda T, Cai Z, Yang S, Lenny N, Lyu CJ, van Deursen JM, Harada H, Downing JR . 1998 Blood 91: 3134–3143
Okuda T, van Deursen J, Hiebert SW, Grosveld G, Downing JR . 1996 Cell 84: 321–330
Pane F, Mostarda I, Selleri C, Salzano R, Raiola AM, Luciano L, Saglio G, Rotoli B, Salvatore F . 1999 Blood 94: 2200–2207
Pawson T . 1995 Nature 373: 573–580
Pear WS, Nolan GP, Scott ML, Baltimore D . 1993 Proc. Natl. Acad. Sci. USA 90: 8392–8396
Pear WS, Miller JP, Xu L, Pui JC, Soffer B, Quackenbush RC, Pendergast AM, Bronson R, Aster JC, Scott ML, Baltimore D . 1998 Blood 92: 3780–3792
Pendergast AM, Quilliam LA, Cripe LD, Bassing CH, Dai Z, Li N, Batzer A, Rabun KM, Der CJ, Schlessinger J, Gishizky ML . 1993 Cell 75: 175–185
Pfeffer LM, Dinarello CA, Herberman RB, William BRG, Borden EC, Bordens R, Walter MR, Nagabhushan TL, Trotta PP, Pestka S . 1998 Cancer Res. 58: 2489–2499
Pluk H, Dorey K, Superti-Furga G . 2002 Cell 108: 247–259
Ren R . 2002 Leukemia and Lymphoma 8: 1549–1561
Rosenberg N, Witte ON . 1988 Advances in virus research Vol. 35 New York: Academic Press, Inc pp 39–81
Roumiantsev S, de Aos IE, Varticovski L, Ilaria RL, Van Etten RA . 2001 Blood 97: 4–13
Sawyers CL . 1997 Baillieres Clin. Haematol. 10: 223–231
Sawyers CL . 2001 Semin. Hematol. 38: 15–21
Schmidt M, Hochhaus A, Nitsche A, Hehlmann R, Neubauer A . 2001 Blood 97: 3648–3650
Schmidt M, Nagel S, Proba J, Thiede C, Ritter M, Waring JF, Rosenbauer F, Huhn D, Wittig B, Horak I, Neubauer A . 1998 Blood 91: 22–29
Sexl V, Piekorz R, Moriggl R, Rohrer J, Brown MP, Bunting KD, Rothammer K, Roussel MF, Ihle JN . 2000 Blood 96: 2277–2283
Shuai K, Halpern J, ten Hoeve J, Rao X, Sawyers CL . 1996 Oncogene 13: 247–254
Sillaber C, Gesbert F, Frank DA, Sattler M, Griffin JD . 2000 Blood 95: 2118–2125
Socolovsky M, Fallon AE, Wang S, Brugnara C, Lodish HF . 1999 Cell 98: 181–191
Sood R, Talwar-Trikha A, Chakrabarti SR, Nucifora G . 1999 Leukemia 13: 348–357
Talpaz M . 2001 Semin. Hematol. 38: 22–27
Tamura T, Nagamura-Inoue T, Shmeltzer Z, Kuwata T, Ozato K . 2000 Immunity 13: 155–165
Tanaka T, Mitani K, Kurokawa M, Ogawa S, Tanaka K, Nishida J, Yazaki Y, Shibata Y, Hirai H . 1995 Mol. Cell. Biol. 15: 2383–2392
Teglund S, McKay C, Schuetz E, van Deursen JM, Stravopodis D, Wang D, Brown M, Bodner S, Grosveld G, Ihle JN . 1998 Cell 93: 841–850
Van Etten RA . 2001 Blood Cells Mol. Dis. 27: 201–205
Verfaillie CM, Hurley R, Lundell BI, Zhao C, Bhatia R . 1997 Acta Haematol. 97: 40–52
Voncken JW, Griffiths S, Greaves MF, Pattengale PK, Heisterkamp N, Groffen J . 1992 Cancer Res. 52: 4534–4539
Voncken JW, Kaartinen V, Pattengale PK, Germeraad WT, Groffen J, Heisterkamp N . 1995 Blood 86: 4603–4611
Wang Q, Stacy T, Binder M, Marin-Padilla M, Sharpe AH, Speck NA . 1996 Proc. Natl. Acad. Sci. USA 93: 3444–3449
Westendorf JJ, Yamamoto CM, Lenny N, Downing JR, Selsted ME, Hiebert SW . 1998 Mol. Cell. Biol. 18: 322–333
Wolff NC, Ilaria Jr RL . 2001 Blood 98: 2808–2816
Wong S, Witte ON . 2001 Oncogene 20: 5644–5659
Yaish P, Gzit A, Gilon C, Levitzki A . 1988 Science 242: 933–935
Yergeau DA, Hetherington CJ, Wang Q, Zhang P, Sharpe AH, Binder M, Marin-Padilla M, Tenen DG, Speck NA, Zhang DE . 1997 Nat. Genet. 15: 303–306
Zhang X, Ren R . 1998 Blood 92: 3829–3840
Zhang X, Subrahmanyam R, Wong R, Gross AW, Ren R . 2001a Mol. Cell. Biol. 21: 840–853
Zhang X, Wong R, Hao SX, Pear WS, Ren R . 2001b Blood 97: 277–287
Zhao X, Ghaffari S, Lodish H, Malashkevich VN, Kim PS . 2002 Nat. Struct. Biol. 9: 117–120
Zou X, Calame K . 1999 J. Biol. Chem. 274: 18141–18144
Acknowledgements
I thank Alec W Gross and Ramesh Subrahmanyam for their critical reading of this review. This work was supported by National Cancer Institute grant CA68008 and by ACS Grant RSG-02-059-01-LIB. R Ren is a recipient of The Leukemia and Lymphoma Society Scholar Award.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ren, R. The molecular mechanism of chronic myelogenous leukemia and its therapeutic implications: studies in a murine model. Oncogene 21, 8629–8642 (2002). https://doi.org/10.1038/sj.onc.1206090
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1206090
Keywords
This article is cited by
-
Eliminating chronic myeloid leukemia stem cells by IRAK1/4 inhibitors
Nature Communications (2022)
-
Stem cell persistence in CML is mediated by extrinsically activated JAK1-STAT3 signaling
Leukemia (2019)
-
An inhibitor-resistant mutant of Hck protects CML cells against the antiproliferative and apoptotic effects of the broad-spectrum Src family kinase inhibitor A-419259
Oncogene (2008)
-
Mechanisms of BCR–ABL in the pathogenesis of chronic myelogenous leukaemia
Nature Reviews Cancer (2005)